-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901.O4.6 901. Health Services and Outcomes Research – Non-Malignant Conditions: Health Outcomes in Inherited and Acquired Bleeding Disorders

Health Services and Outcomes Research – Non-Malignant Conditions Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 5, 2015: 7:30 AM-9:00 AM
W230, Level 2 (Orange County Convention Center)
Moderators:
Deirdra Terrell, PhD, The University of Oklahoma Health Sciences Center and Cindy Neunert, MD, The University of Texas Southwestern Medical Center at Dallas and Children's Medical Center Dallas

Disclosures:
No relevant conflicts of interest to declare.
7:30 AM
37
Effect of Romiplostim on Health-Related Quality of Life in Children with Immune Thrombocytopenia and Associated Burden in Their Parents: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled StudyClinically Relevant Abstract

Susan D Mathias, MPH1*, Xiaoyan Li, PhD2*, Melissa Eisen, MD2*, Nancy Carpenter, MSc2*, Ross D Crosby, PhD1,3,4* and Victor S. Blanchette, MD, FRCP5

1Health Outcomes Solutions, Winter Park, FL
2Amgen Inc., Thousand Oaks, CA
3Neuropsychiatric Research Institute, Fargo, ND
4University of North Dakota School of Medicine and Health Sciences, Fargo, ND
5The Hospital for Sick Children, Toronto, ON, Canada
7:45 AM
38
Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample DataClinically Relevant Abstract

Shuling Li, PhD1*, Julia T Molony, MS1*, Karynsa Cetin, MPH2*, Jeffrey S Wasser, MD3 and Ivy Altomare, MD4*

1Chronic Disease Research Group, Minneapolis, MN
2Center for Observational Research, Amgen Inc, Cambridge, MA
3Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, CT
4Division of Medical Oncology, Duke University Medical Center, Durham, NC
8:00 AM
39
Impact of Pain and Functional Impairment in US Adult People with Hemophilia (PWH): Patient-Reported Outcomes and Musculoskeletal Evaluation in the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Christine L Kempton, MD, MSc1, Michael Recht, MD, PhD2*, Anne Neff, MD3, Michael Wang, MD4, Tyler W. Buckner, MD, MSc5, Amit Soni, MD6*, Doris Quon, MD, PhD7, Michelle Witkop, DNP, FNP-BC8*, Lisa Boggio, MD9 and David L Cooper, MD, MBA10*

1Emory University, Atlanta, GA
2The Hemophilia Center, Oregon Health & Science University, Portland, OR
3Cleveland Clinic, Cleveland, OH
4University of Colorado School of Medicine, Aurora, CO
5Divisions of Hematology and Pediatric Hematology/Oncology, Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO
6Children's Hospital of Orange County, Orange, CA
7Orthopaedic Hemophilia Treatment Center, Los Angeles, CA
8Munson Medical Center, Traverse city, MI
9Rush University Medical Center, Chicago, IL
10Novo Nordisk Inc, Plainsboro, NJ
8:15 AM
40
Numeracy in Patients with HemophiliaClinically Relevant Abstract

Duc Q. Tran, MD, MSc1, Vaughn Barry, PhD, MPH2, Ana G. Antun, MD1, Maria Ribeiro, MD1*, Sidney F. Stein, MD1 and Christine L Kempton, MD, MSc1,2

1Department of Hematology & Medical Oncology, Emory University School of Medicine, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
8:30 AM
41
Outcomes of Referrals for Mild and Moderate ThrombocytopeniaClinically Relevant Abstract

Charles Schlappi, MD1*, David McCall, MD1*, Prasannalaxmi Palabindela, MBBS2*, Christy Bemrich Stolz, MD MSPH2*, Lee Hilliard, MD2 and Jeffrey D. Lebensburger, DO2

1University of Alabama at Birmingham, Birmingham, AL
2Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL
8:45 AM
42
Content, Utilization and Impact of a Hematology e-Consultation Service

Karima Khamisa, MD, FRCPC1, Adam Fogel, BSc2, Clare Liddy, MD, MSc, CCFP, FCFP3*, Erin Keely, MD, FRCPC4* and Amir Afkham, BEng5*

1Division of Haematology, University of Ottawa, Ottawa, ON, Canada
2University of Ottawa, Ottawa, ON, Canada
3C.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute, Ottawa, ON, Canada
4Division of Endocrinology, The Ottawa Hospital, Ottawa, ON, Canada
5Champlain Local Health Integration Network, Ottawa, ON, Canada
See more of: Health Services and Outcomes Research – Non-Malignant Conditions
See more of: Oral and Poster Abstracts
<< Previous Session | Next Session >>

*signifies non-member of ASH